pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-92a-1 |
Genomic Coordinates | chr14: 115044427 - 115044506 |
Description | Mus musculus miR-92a-1 stem-loop |
Comment | The predominant miR-92 form cloned by Landgraf et al. has a additional 3' U residue, which is compatible with this precursor sequence, but not with that of mir-92-2 (MIR:MI0000580) . |
RNA Secondary Structure | |
pre-miRNA | mmu-mir-92a-2 |
Genomic Coordinates | chrX: 52741838 - 52741928 |
Description | Mus musculus miR-92a-2 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-92a-3p |
Sequence | 50| UAUUGCACUUGUCCCGGCCUG |70 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Trp63 | ||||||||||||||||||||
Synonyms | AI462811, Ket, P51/P63, P63, P73l, Tp63, Trp53rp1 | ||||||||||||||||||||
Description | transformation related protein 63 | ||||||||||||||||||||
Transcript | NM_001127260 | ||||||||||||||||||||
Other Transcripts | NM_001127259 , NM_001127261 , NM_001127262 , NM_001127263 , NM_001127264 , NM_001127265 , NM_011641 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Trp63 | |||||||||||||||||||||
3'UTR of Trp63 (miRNA target sites are highlighted) |
>Trp63|NM_001127260|3'UTR 1 AGATCCCTGAACAGTTCCGACATGCCATCTGGAAGGGCATCCTGGACCACAGGCAGCTGCACGACTTCTCCTCACCTCCT 81 CATCTCCTGAGGACCCCAAGTGGTGCCTCTACCGTCAGTGTGGGCTCCAGTGAGACCCGTGGTGAACGTGTGATCGATGC 161 CGTGCGCTTTACCCTCCGCCAGACCATCTCTTTTCCACCCCGTGACGAGTGGAATGATTTCAACTTTGACATGGATTCTC 241 GTCGCAACAAGCAGCAGCGTATCAAAGAGGAAGGAGAATGAGCGCCCATTGCGGGGTTCTTCCTGTCTTCTTCCACCTCC 321 CAGCCCCTACAGGGCACGCCTGCTTGATCCTCAGAGCCTTCTCGTTAGCTCTTCTCCTTCTCCTTCTCAGTCTGGTTTCT 401 AAAGGGACGGAGAATTAGGAGGCTGCCTGTTACCTAAAGTCTGACCTGTCACCTGATTCTGATTCTGGCTTTAAGCCTTC 481 AATACTCTTGCTTGCAAGATGCATTGACATTGCTAGATAGAAGTTAGCAAAGAAGCAGTAGGTCTCTTTAAGCAGTGGAG 561 ATCTCTCATTGACTTTTATAAAGCATTTTCAGCCTTATAGTCTAAGACTATATATATAAATATATAAATATCCGATATAT 641 ATTTTGGGTGTGGGGGGTATTGAGTATTGTTTAAATGTAATTTAATGGAAATTGAGTTGCACTTATCATCCTTCTTTGGA 721 ATTTGCTTGTTTCGGATGGCTGAGCTGTACTCCTTTCTCAGGGGTATCATGTATGGTGACAGATATCTAGAGTTGAATGG 801 TCTATGTGAGTAACAATGACGTATAGGACCTCTCCTCATCCTTTGGATGGTTATTGTTTAGCACATCAAACCTGTGGATG 881 CATCCAGTGTGTTTACCATTGCTTCCTATGAGGTAAAACTGTATATATGTACACAGTTTTCTCTGTCAGTATATTTTATG 961 TTACTGGTGTCCATTCCAGTTAGGCTGGTTCACTCTGTGGCTATTACAAGCCACATTTTAGGTTTGCTTTGTCACACACT 1041 ATAAGACAGGGCATTGTCTCTTGCTTTTGTTTGAGAATGAGGAATGCAGTTGTGTTGTGGTTTGTTTTGTTTTATTTTGT 1121 TTTGTTTTCTGGAAACTCTTAAATGGTTCAAGTCAGCCATTCCAAATATCTGATGAAATTTAGCCCAATATAGCAGTAGC 1201 TCTTTGAAATTTAAGGCCCAACACCCTAGTATTTATTAGAAAAATAAACATTTGCTGTTGTTAGAATAGTCTTAAAAATA 1281 AATTTCTCTGCTAGATTGACTAAGTAAAATAGACATTCTCTGCTGTTGTGAGAATTTGGGCCAATTAGAATGAATGAAAT 1361 TCGTCTAGTTTTCATGGGGAGTTGTAATGTCTATTAGAAAGATTCAGGAAAAATAAGAATGATTCAGAAATACTGAATTT 1441 CCATGAAAAGGAAAACAGAAAGCGATTCATCCCACCAAACTCTGAATTGAAGTTCCTTTTGAAGGGTGGAGTGATGCTTG 1521 GGAAGTGGACCTTTTAAAGACTTTCCTATCTATGAGACACTGCATGCACAGGCAAGTTTCTCTCTCCCCAAGGGCTAAAA 1601 TAAGAATAATGGCTTGGAAAATACAAACTTCGTAGTGTAGTTTTCACATAGCATGAGCTGAACCACTGTTATCTTCCTCT 1681 TGATCATCAAAGCTTCATTGTTTTAGAAAGCAGAGGTGAAGACCCAGTTTTCCGCCTGACACTTTCCAAGCTAGTGTAGA 1761 CCAAGACCTGTCTACAAACCCACGACAAACCTTTTCACCTGTTTAATCCATATCCAGAAAGACTTGTTTCATACCTTGGG 1841 AAAGCATGCAACAGTATTCCCCTTAGATATTTTGGAAACATTTTGAGACAAGTATATTTTTTTTCCTGCCTAAACCAAGT 1921 GTTGTTTGTATGCTAATGAGCTCTACAATCTTCCCACACATTTTGTTAAATGACTTTCATTGCACATGAGCTCCCATTTT 2001 TTATTTTAAAGTGCAAATGGGCTAATAGGCCTTTGACGTGTAATGTATGAGTTTTGCCAGAAAATCATATCTTGTGTATA 2081 TGCGTGTGTGTGAAATTGCTTACTATGCTGGTTTTGTTTGTTATGGCTTTCTCTTTGGGATAGTTGGGTTTTCCAGAACC 2161 ACAGATGAAACTTTTTTTGTTGCTATTTTTATATTTTTGCAGAAACACCGTTTAGTGAGAATTCAATGTCAAATATGACA 2241 TGATACCTTAATTGTAAGAAGAAGGTGGGAAGGGAAAGTTGGTTTATTAATTTTTTTAAATTTTGTATGCAAAAGCAAAT 2321 GAGTCCTTAATTTCAACATTTTGTTGTGTTTAAATAATGATAAGCATCATTAACTTCTGTAACAAACTCACAGCTTTACA 2401 AATTCAATGGGTGGAGAAGAAAGCTGTGTCTTAGCCATGTTAGGAAGACAAATGGCTTCCTGTGTGTTGTAAGTATTTGG 2481 GCTGTTTCAGCAGTGTTGGTGTGGCACAGGGGACTCTGTGGCATTTCAGCACTATTTAGGTGGCACTAGGGACTCTGAAA 2561 TTCCTGTACTGTATCTGATGATTTTGGCATTAGCCATAGGTAGGCACAGTTTGTCTCCTCACACCAGTGTTTAGTGTGTG 2641 AATAGCCAGAGCTGTGGGGAAGAACACAGAGAACAGACATCTGCTGGATGCCTCTCAGTGGAGAATGGGATTCCTTCACT 2721 TGGTGGTGAAGCAGATAGGATAGAAAGCAGGATTCTCTTTGTTAATCCAGTTAGCTTTTGTTTTCTTGATATCCCCCCTG 2801 AATACGTTGAGTATGAGAGATATGTGGGTTTTTTTTATTTTTATAATTGTACAAAATTAAGCAAATATCAAATGTTTTAT 2881 ATACTTTATTAATGTTTTTTTTCAAAAGGTACTTTCTTATAGACATGATACTTTTTTACAGCTTCAGTTGCTTGTCTTCT 2961 GGTATTTTTGTGTTATGGGCTATGGTGAGCCAGAGGCAAATCTATAAGCCATTTTTGTTTGCCAGGACATGCAATAAAAT 3041 TTAAAAATAAATGAAAATACACTGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | 32D |
Location of target site | 3'UTR |
Tools used in this research | miRanda |
Original Description (Extracted from the article) |
...
Tbeta
... - Manni I; Artuso S; Careccia S; Rizzo MG; et al., 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology. |
Article |
- Manni I; Artuso S; Careccia S; Rizzo MG; et al. - FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009
MicroRNAs (miRs) are 21- to 23-nucleotide RNA molecules that regulate the stability or translational efficiency of target messenger RNAs of proteins involved in cell growth and apoptosis. miR-92 is part of the mir-17-92 cluster, which comprises members with an effect on cell proliferation. However, the role of miR-92 is unknown, and its targets have not been identified. Here, we describe a mechanism through which miR-92 contributes to regulate cell proliferation. Using a miR-92 synthetic double-strand oligonucleotide, we demonstrate that miR-92 increases 32D myeloid cell proliferation and 5-bromo-2-deoxyuridine (BrdU) incorporation and inhibits cell death. The effect is miR-92 specific since the miR-92 antagomir inhibits cell proliferation. Moreover, we show that miR-92 acts by modulating p63-isoform abundance through down-regulatation of endogenous DeltaNp63beta. Using luciferase reporters containing p63 3'UTR fragments with wild-type or mutant miR-92 complementary sites, we demonstrate that the wild-type 3'UTR is a direct target of miR-92. Finally, we observed that a miR-92-resistant DeltaNp63beta isoform (without 3'UTR) inhibits cell proliferation and parallels the effect of the antagomir. We conclude that one of the molecular mechanisms through which miR-92 increases cell proliferation is by negative regulation of an isoform of the cell-cycle regulator p63.
LinkOut: [PMID: 19608627]
|
24 mmu-miR-92a-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT002971 | Hipk3 | homeodomain interacting protein kinase 3 | 2 | 1 | ||||||||
MIRT002978 | Mylip | myosin regulatory light chain interacting protein | 3 | 1 | ||||||||
MIRT004280 | Trp63 | transformation related protein 63 | 4 | 1 | ||||||||
MIRT007244 | Map2k4 | mitogen-activated protein kinase kinase 4 | 1 | 1 | ||||||||
MIRT053813 | Zfpm2 | zinc finger protein, multitype 2 | 3 | 1 | ||||||||
MIRT054699 | Tbx3 | T-box 3 | 3 | 2 | ||||||||
MIRT054792 | Shox2 | short stature homeobox 2 | 1 | 1 | ||||||||
MIRT578185 | Ncam2 | neural cell adhesion molecule 2 | 1 | 1 | ||||||||
MIRT580680 | Stk10 | serine/threonine kinase 10 | 1 | 3 | ||||||||
MIRT583677 | Fam136a | family with sequence similarity 136, member A | 1 | 1 | ||||||||
MIRT584193 | Cpeb1 | cytoplasmic polyadenylation element binding protein 1 | 1 | 1 | ||||||||
MIRT587067 | Gm5148 | predicted gene 5148 | 1 | 2 | ||||||||
MIRT589036 | Rhbdl3 | rhomboid, veinlet-like 3 (Drosophila) | 1 | 1 | ||||||||
MIRT595174 | Zpbp | zona pellucida binding protein | 1 | 1 | ||||||||
MIRT595805 | Chm | choroidermia (RAB escort protein 1) | 1 | 1 | ||||||||
MIRT595903 | Cd69 | CD69 antigen | 1 | 1 | ||||||||
MIRT596292 | Tagap1 | T cell activation GTPase activating protein 1 | 1 | 1 | ||||||||
MIRT596301 | Tagap | T cell activation Rho GTPase activating protein | 1 | 1 | ||||||||
MIRT596475 | Btg2 | B cell translocation gene 2, anti-proliferative | 1 | 1 | ||||||||
MIRT598598 | Il5ra | interleukin 5 receptor, alpha | 1 | 1 | ||||||||
MIRT598840 | Gm14420 | zinc finger protein 970 | 1 | 1 | ||||||||
MIRT601409 | Uba1y | ubiquitin-activating enzyme, Chr Y | 1 | 1 | ||||||||
MIRT606063 | Zfp300 | zinc finger protein 300 | 1 | 1 | ||||||||
MIRT735310 | PTEN | phosphatase and tensin homolog | 3 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|